EPISODE · Nov 25, 2019 · 10 MIN
Biostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal Implants
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed Biostage, Inc. (BSTG)(“the Company”), a bioengineering company that is developing next-generation esophageal implants. CEO of the Company, Jim McGorry, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Embed this episode
NOW PLAYING
Biostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal Implants
No transcript for this episode yet
Similar Episodes
No similar episodes found.